π
|
OPA1 Isoforms in the Hierarchical Organization of Mitochondrial Functions.
15 auth.
V. Dotto,
V. Dotto,
Prashant Mishra,
S. Vidoni,
M. Fogazza,
A. Maresca,
L. Caporali,
J. Mccaffery,
M. Cappelletti,
E. Baruffini,
...
G. Lenaers,
D. Chan,
M. Rugolo,
V. Carelli,
C. Zanna
|
7 |
2017 |
7 π
|
π¬
|
Eight human OPA1 isoforms, long and short: What are they for?
Valentina Del Dotto,
M. Fogazza,
V. Carelli,
M. Rugolo,
C. Zanna
|
7 |
2018 |
7 π¬
|
π¬
|
OPA1: How much do we know to approach therapy?
Valentina Del Dotto,
M. Fogazza,
G. Lenaers,
M. Rugolo,
V. Carelli,
C. Zanna
|
5 |
2018 |
5 π¬
|
π
|
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models.
15 auth.
Valentina Del Dotto,
M. Fogazza,
F. Musiani,
A. Maresca,
S. J. Aleo,
L. Caporali,
C. La Morgia,
C. Nolli,
T. Lodi,
P. Goffrini,
...
D. Chan,
V. Carelli,
M. Rugolo,
E. Baruffini,
C. Zanna
|
5 |
2018 |
5 π
|
π¦
|
Formation of anodic films on sputtering-deposited Al-Hf alloys
8 auth.
M. Fogazza,
M. SantamarΓa,
F. Quarto,
S. GarciaβVergara,
I. S. Molchan,
P. Skeldon,
...
G. Thompson,
H. Habazaki
|
4 |
2009 |
4 π¦
|
π
|
Metabolomics hallmarks OPA1 variants correlating with their in vitro phenotype and predicting clinical severity
13 auth.
J. M. Chao De La Barca,
M. Fogazza,
M. Rugolo,
S. Chupin,
Valentina Del Dotto,
A. Ghelli,
V. Carelli,
G. Simard,
V. Procaccio,
D. Bonneau,
...
G. Lenaers,
P. Reynier,
C. Zanna
|
4 |
2020 |
4 π
|
π
|
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations
11 auth.
S. J. Aleo,
Valentina Del Dotto,
M. Fogazza,
A. Maresca,
T. Lodi,
P. Goffrini,
...
A. Ghelli,
M. Rugolo,
V. Carelli,
E. Baruffini,
C. Zanna
|
3 |
2020 |
3 π
|
π¦
|
Biochemical characterization and validation of a novel cellmodel for dominant optic atrophy.
M. Fogazza
|
0 |
2018 |
0 π¦
|